Dermal elastolysis in the setting of combination immunotherapy.
J Cutan Pathol
; 46(9): 684-687, 2019 Sep.
Article
em En
| MEDLINE
| ID: mdl-31074019
ABSTRACT
Multiple cutaneous side effects have been reported with the use of immunotherapies including programmed cell death protein 1 inhibitors. We report 2 patients who presented with papillary dermal elastolysis presenting as multiple, skin-colored, wrinkled papules and atrophic macules following an inflammatory eruption in the setting of combination chemotherapy with nivolumab and cabiralizumab. These two cases highlight a novel finding, elastolysis in the setting of chemotherapy with nivolumab and cabiralizumab.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Pigmentação da Pele
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Toxidermias
Limite:
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
J Cutan Pathol
Ano de publicação:
2019
Tipo de documento:
Article